Molecular Diagnostics
DNA Sequencing of MRSA Predicts Patient Survival
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that has become resistant to most types of antibiotics, and up to 20% of patients with invasive infections die. Although S. aureus is a common bacterium that lives on the skin, if it gets inside the body through a cut it can cause septicemia. More...23 Aug 2017
New Molecular Test Identifies Colorectal Cancer
Colorectal cancer is one of the leading causes of cancer-related deaths worldwide, with more than 600,000 deaths each year. Among individuals undergoing treatment for the disease, recurrence occurs in 30% to 50% of all cases. The majority of these cases present in the first two to three years following initial diagnosis and treatment. More...23 Aug 2017
CRISPR Technology Identifies Cancer-Causing Genes
Researchers have identified specific gene combinations that can cause the brain cancer glioblastoma, using their newly developed modified CRISPR technology that can also pinpoint triggers and primary drivers of other types cancers. Thus the new technology could help improve diagnostics, as well as in finding more specific targets for developing more effective drugs. More...22 Aug 2017
Liquid Biopsy Approach Inspired by Swarm Behavior
Researchers have designed an algorithm for blood sample analysis where, rather than testing for evidence of cancer DNA or protein biomarkers, they test for tumor cell RNA absorbed by circulating platelets – i.e. thrombocytes. In a new study, they designed the test to diagnose non-small cell lung cancers (NSCLCs), which make up the majority of lung cancer cases, and achieved ~90% accuracy on a validation control group. More...21 Aug 2017
Cytokine Concentration Linked to Chronic Fatigue Syndrome
More than one million people in the USA suffer from chronic fatigue syndrome, also known as myalgic encephomyelitis and designated by the acronym ME/CFS. It is a disease with no known cure or even reliably effective treatments. More...16 Aug 2017
Mutations Related to Hereditary Neuroendocrine Tumors
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors with a strong hereditary component and half the genes whose alterations confer hereditary susceptibility to develop this condition code for enzymes involved in the Krebs cycle. More...16 Aug 2017
Gold Member
Hematology Analyzer
Medonic M32B
Silver Member
PCR Plates
Diamond Shell PCR Plates
 assay.jpg)
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
In Other News
Blood Test Detects Brain Metastases While Treatable
Neurological Disease Traced to Gene Error
Smartphone-Based ELISA Developed for Blood Antigens
Dried Blood Assessment Equivalent to Drawn Blood Samples
Test Discriminates Between Viral and Bacterial Infections
CRISPR Illuminates Pediatric Bone Marrow Failure Syndrome
Five Vascular Diseases Linked to One Genetic Variant
Liquid Biopsy Could Identify Advanced Breast Cancer Patients
Methods Compared for Chagas Disease Diagnosis
Study Shows Predisposed Cancer Factors in Ashkenazi Jewish Women
Breast Cancer Diagnosed by Measuring Circulating Tumor DNA
Study Highlights Ethnic Diversity of Lupus-Linked Genes
New Genes Found Raise Alzheimer’s Disease Risk
Genetic Variation Associated with Influenza Severity Identified
Newly Driver Mutations Discovered for Medulloblastoma
Antibody-Based ELISA Detects Zika with High Specificity
Novel Non-Invasive Sampling Technique Diagnoses Cutaneous Leishmaniasis
RT-PCR Evaluated for Taenia Detection
Bacterium Actively Drives CRC Tumor Growth
Specific MicroRNA Identifies Glioblastoma Subtypes
MicroRNA Technology Proves Useful for Liver Toxicity Detection
Genomic Variants Contribute to Cognitive Impairment
Molecular Testing Evaluated for Thyroid Nodules
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.